Cover Kidney News
Volume/Issue:
Volume 14: Issue 10/11
Page:
29
Publication Date:
01 Oct 2022
Online Publication Date:
01 Oct 2022
  • 1.

    Chaturvedi S, et al. The path to chronic kidney disease following acute kidney injury: A neonatal perspective. Pediatr Nephrol 2017; 32:227–241. doi: 10.1007/s00467-015-3298-9

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Crump C, et al. Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: National cohort study. BMJ 2019; 365:l1346. doi: 10.1136/bmj.l1346

  • 3.

    Gjerde A, et al. Intrauterine growth restriction and risk of diverse forms of kidney disease during the first 50 years of life. Clin J Am Soc Nephrol 2020; 15:1413–1423. doi: 10.2215/CJN.04080320

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Harer MW, et al. Follow-up of acute kidney injury in neonates during childhood years (FANCY): A prospective cohort study. Pediatr Nephrol 2017; 32:1067–1076. doi: 10.1007/s00467-017-3603-x

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Sanderson KR, et al. Albuminuria, hypertension, and reduced kidney volumes in adolescents born extremely premature. Front Pediatr 2020; 8:230. doi: 10.3389/fped.2020.00230

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Brenner BM, et al. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1:335–347. doi: 10.1093/ajh/1.4.335

  • 7.

    Hingorani S, et al. Prevalence and risk factors for kidney disease and elevated BP in 2-year-old children born extremely premature. Clin J Am Soc Nephrol [published online ahead of print July 19, 2022]. doi: 10.2215/CJN.15011121; https://cjasn.asnjournals.org/content/17/8/1129

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    ClinicalTrials.gov. Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) (PENUT). https://clinicaltrials.gov/ct2/show/NCT01378273

Editorial Type:
Feature

Extreme Prematurity and Kidney Outcomes: Should We Care?

Tahagod Mohamed Tahagod Mohamed, MD, is the Neonatal Nephrology Program Director in The Kidney and Urinary Tract Center at Nationwide Children's Hospital and an Assistant Professor of Pediatrics at The Ohio State University College of Medicine, Columbus. Michelle Starr, MD, holds joint appointments in Pediatric Nephrology and Pediatric and Adolescent Comparative Effectiveness Research at Riley Children's Health and is an Assistant Professor of Pediatrics at Indiana University School of Medicine, Indianapolis.

Search for other papers by Tahagod Mohamed in
Current site
Google Scholar
PubMed Close
and
Michelle Starr Tahagod Mohamed, MD, is the Neonatal Nephrology Program Director in The Kidney and Urinary Tract Center at Nationwide Children's Hospital and an Assistant Professor of Pediatrics at The Ohio State University College of Medicine, Columbus. Michelle Starr, MD, holds joint appointments in Pediatric Nephrology and Pediatric and Adolescent Comparative Effectiveness Research at Riley Children's Health and is an Assistant Professor of Pediatrics at Indiana University School of Medicine, Indianapolis.

Search for other papers by Michelle Starr in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 14: Issue 10/11
Publication Date:
01 Oct 2022
Page:
29
Restricted access
Save